MRNA Data Readout: a negative outcome, -23.5%

On August 20, 2026, Moderna, Inc. reached its Data Readout. The result was a negative outcome, and the stock moved -23.5% in the window around the event. It had already run +8.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.